Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Aug. 31, 2021 |
Aug. 31, 2020 |
Aug. 31, 2021 |
Aug. 31, 2020 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||
| Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
| Expenses | ||||
| Research and development (Note 14) | 5,284,797 | 2,749,222 | 13,922,632 | 4,229,810 |
| General and administrative (Note 15) | 3,116,226 | 2,049,241 | 6,276,797 | 4,002,323 |
| Depreciation and amortization (Notes 6 and 7) | 140,770 | 302,587 | 272,770 | 558,561 |
| Interest and other financial expenses (Note 19) | 33,102 | (58,905) | 63,689 | 67,871 |
| Interest income | (8,413) | (18,039) | (18,174) | (58,386) |
| Foreign exchange loss (gain) | (174,066) | 103,618 | 32,066 | 180,259 |
| Total expenses | 8,392,416 | 5,127,724 | 20,549,780 | 8,980,438 |
| Net Loss | (8,392,416) | (5,127,724) | (20,549,780) | (8,980,438) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustment | (353,713) | 402,812 | (146,898) | 232,400 |
| Comprehensive income (loss) | $ (8,746,129) | $ (4,724,912) | $ (20,696,678) | $ (8,748,038) |
| Loss per share | ||||
| Basic and Diluted | $ (0.19) | $ (0.13) | $ (0.47) | $ (0.22) |
| Weighted average common shares outstanding | ||||
| Basic and Diluted | 44,132,872 | 39,928,047 | 43,282,989 | 39,922,443 |